No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs551866950 |
chr1:226138320-226138321 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs376537822 |
chr1:226138346-226138347 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs114814066 |
chr1:226138356-226138357 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs149767773 |
chr1:226138377-226138378 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs151020050 |
chr1:226138383-226138384 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs555840615 |
chr1:226138402-226138403 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs146314698 |
chr1:226138434-226138435 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs74150568 |
chr1:226138464-226138465 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs556871195 |
chr1:226138563-226138564 |
Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs56127792 |
chr1:226138606-226138607 |
Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs533589834 |
chr1:226138608-226138609 |
Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs374795375 |
chr1:226138698-226138699 |
Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs578136229 |
chr1:226138744-226138745 |
Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs191522771 |
chr1:226138762-226138763 |
Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs148658771 |
chr1:226138844-226138845 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs572094911 |
chr1:226138892-226138893 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs542303865 |
chr1:226138947-226138948 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs560583322 |
chr1:226138972-226138973 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs144458777 |
chr1:226138981-226138982 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs73131866 |
chr1:226139014-226139015 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs149182491 |
chr1:226139053-226139054 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs113931174 |
chr1:226139065-226139066 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs377219229 |
chr1:226139126-226139127 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs532342058 |
chr1:226139215-226139216 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs547226017 |
chr1:226139221-226139222 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs183820855 |
chr1:226139222-226139223 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs565861648 |
chr1:226139224-226139225 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs373850883 |
chr1:226139251-226139252 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs186338647 |
chr1:226139252-226139253 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs567687908 |
chr1:226139272-226139273 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs538207850 |
chr1:226139342-226139343 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs12064281 |
chr1:226139346-226139347 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs556906104 |
chr1:226139373-226139374 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs55957490 |
chr1:226139374-226139375 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs537982160 |
chr1:226139424-226139425 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs75626985 |
chr1:226139426-226139427 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs552774365 |
chr1:226139432-226139433 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs191442648 |
chr1:226139437-226139438 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs34510718 |
chr1:226139573-226139574 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs182080198 |
chr1:226139592-226139593 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs577544688 |
chr1:226139593-226139594 |
Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs540026143 |
chr1:226139628-226139629 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs142415966 |
chr1:226139715-226139716 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs542340855 |
chr1:226139725-226139726 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs114057453 |
chr1:226139827-226139828 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs575645835 |
chr1:226139832-226139833 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs114695208 |
chr1:226139858-226139859 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs542409315 |
chr1:226139873-226139874 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs150952487 |
chr1:226139901-226139902 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs542467639 |
chr1:226139960-226139961 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|